Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center

We evaluate differences in outcomes in younger (<65 years) and older (≥65 years) patients for target lesion failure (TLF) at 2-year follow-up in an unselected consecutive series of patients treated with the everolimus- (EES) and paclitaxel-eluting (PES) stents at a tertiary medical center. 348 co...

Full description

Saved in:
Bibliographic Details
Main Authors: Nicolas W. Shammas, Gail A. Shammas, Peter Sharis, Michael Jerin
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Journal of Aging Research
Online Access:http://dx.doi.org/10.1155/2013/471026
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545576058617856
author Nicolas W. Shammas
Gail A. Shammas
Peter Sharis
Michael Jerin
author_facet Nicolas W. Shammas
Gail A. Shammas
Peter Sharis
Michael Jerin
author_sort Nicolas W. Shammas
collection DOAJ
description We evaluate differences in outcomes in younger (<65 years) and older (≥65 years) patients for target lesion failure (TLF) at 2-year follow-up in an unselected consecutive series of patients treated with the everolimus- (EES) and paclitaxel-eluting (PES) stents at a tertiary medical center. 348 consecutive patients (younger 150; older 198) stented with the EES and PES were retrospectively analyzed. The primary endpoint was TLF (composite endpoint of cardiac death, non fatal myocardial infarction due to index vessel and target lesion revascularization (TLR)). At 2 years follow up, younger versus older patients had the following outcomes respectively: TLF 27.7% versus 25.5% (P=0.71), TLR 24.8% versus 21.4% (P=0.52), cardiac death 3.4% versus 2.5% (P=0.75) and definite and probable stent thrombosis (2.0% versus 1.0%). Multivariate analysis showed that renal failure (odds ratio: 2.55, P=0.045), number of stents per patient (odds ratio: 1.60, P=0.001) and younger age (odds ratio: 0.97; P=0.010), but not gender, diabetes or type of DES stent (EES versus PES) predicted TLF. We conclude that older age was not a predictor of TLF at 2-year follow-up after adjusting for renal insufficiency, number of stents used per patient, gender, diabetes and type of DES used.
format Article
id doaj-art-572b3a2cace7452683fb92cabf6f1339
institution Kabale University
issn 2090-2204
2090-2212
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Journal of Aging Research
spelling doaj-art-572b3a2cace7452683fb92cabf6f13392025-02-03T07:25:17ZengWileyJournal of Aging Research2090-22042090-22122013-01-01201310.1155/2013/471026471026Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical CenterNicolas W. Shammas0Gail A. Shammas1Peter Sharis2Michael Jerin3Midwest Cardiovascular Research Foundation, 1236 E Rusholme, Suite 300, Davenport, IA 52803, USAMidwest Cardiovascular Research Foundation, 1236 E Rusholme, Suite 300, Davenport, IA 52803, USAMidwest Cardiovascular Research Foundation, 1236 E Rusholme, Suite 300, Davenport, IA 52803, USAMidwest Cardiovascular Research Foundation, 1236 E Rusholme, Suite 300, Davenport, IA 52803, USAWe evaluate differences in outcomes in younger (<65 years) and older (≥65 years) patients for target lesion failure (TLF) at 2-year follow-up in an unselected consecutive series of patients treated with the everolimus- (EES) and paclitaxel-eluting (PES) stents at a tertiary medical center. 348 consecutive patients (younger 150; older 198) stented with the EES and PES were retrospectively analyzed. The primary endpoint was TLF (composite endpoint of cardiac death, non fatal myocardial infarction due to index vessel and target lesion revascularization (TLR)). At 2 years follow up, younger versus older patients had the following outcomes respectively: TLF 27.7% versus 25.5% (P=0.71), TLR 24.8% versus 21.4% (P=0.52), cardiac death 3.4% versus 2.5% (P=0.75) and definite and probable stent thrombosis (2.0% versus 1.0%). Multivariate analysis showed that renal failure (odds ratio: 2.55, P=0.045), number of stents per patient (odds ratio: 1.60, P=0.001) and younger age (odds ratio: 0.97; P=0.010), but not gender, diabetes or type of DES stent (EES versus PES) predicted TLF. We conclude that older age was not a predictor of TLF at 2-year follow-up after adjusting for renal insufficiency, number of stents used per patient, gender, diabetes and type of DES used.http://dx.doi.org/10.1155/2013/471026
spellingShingle Nicolas W. Shammas
Gail A. Shammas
Peter Sharis
Michael Jerin
Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center
Journal of Aging Research
title Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center
title_full Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center
title_fullStr Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center
title_full_unstemmed Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center
title_short Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center
title_sort age differences in long term outcomes of coronary patients treated with drug eluting stents at a tertiary medical center
url http://dx.doi.org/10.1155/2013/471026
work_keys_str_mv AT nicolaswshammas agedifferencesinlongtermoutcomesofcoronarypatientstreatedwithdrugelutingstentsatatertiarymedicalcenter
AT gailashammas agedifferencesinlongtermoutcomesofcoronarypatientstreatedwithdrugelutingstentsatatertiarymedicalcenter
AT petersharis agedifferencesinlongtermoutcomesofcoronarypatientstreatedwithdrugelutingstentsatatertiarymedicalcenter
AT michaeljerin agedifferencesinlongtermoutcomesofcoronarypatientstreatedwithdrugelutingstentsatatertiarymedicalcenter